Paper33285015
Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease.
Hall S and 6 others. Mov Disord, 2021. Cited by 69 papers, by iCite.
Cite this record
ConductScience Library. Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease. Papers, record 33285015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33285015
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Lewy Body Disease | Major topic |
| Amyloid beta-Peptides | |
| Biomarkers | |
| Cross-Sectional Studies | |
| Humans | |
| Plasma | |
| tau Proteins |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30326496 | Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders. | JAMA | 2018 | https://conductscience.org/library/papers/30326496 | PubMed |
| 2 | 27068280 | CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. | Lancet Neurol | 2016 | https://conductscience.org/library/papers/27068280 | PubMed |
| 3 | 23900411 | Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies. | Nat Rev Neurosci | 2013 | https://conductscience.org/library/papers/23900411 | PubMed |
| 4 | 29549278 | 18F-AV-1451 in Parkinson's Disease with and without dementia and in Dementia with Lewy Bodies. | Sci Rep | 2018 | https://conductscience.org/library/papers/29549278 | PubMed |
| 5 | 32123386 | Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. | Nat Med | 2020 | https://conductscience.org/library/papers/32123386 | PubMed |
| 6 | 12687392 | Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. | Acta Neuropathol | 2003 | https://conductscience.org/library/papers/12687392 | PubMed |
| 7 | 26527105 | Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases. | Neuropathol Appl Neurobiol | 2016 | https://conductscience.org/library/papers/26527105 | PubMed |
| 8 | 32123385 | Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia. | Nat Med | 2020 | https://conductscience.org/library/papers/32123385 | PubMed |
| 9 | 23065790 | Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. | Brain | 2012 | https://conductscience.org/library/papers/23065790 | PubMed |
| 10 | 27979356 | Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. | Lancet Neurol | 2017 | https://conductscience.org/library/papers/27979356 | PubMed |
| 11 | 32183883 | Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification. | Alzheimers Res Ther | 2020 | https://conductscience.org/library/papers/32183883 | PubMed |
| 12 | 30559465 | Dementia with Lewy bodies - from scientific knowledge to clinical insights. | Nat Rev Neurol | 2019 | https://conductscience.org/library/papers/30559465 | PubMed |
| 13 | 32391858 | Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders. | JAMA Neurol | 2020 | https://conductscience.org/library/papers/32391858 | PubMed |
| 14 | 31444276 | Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies. | J Neurol Neurosurg Psychiatry | 2019 | https://conductscience.org/library/papers/31444276 | PubMed |
| 15 | 27323247 | In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. | Ann Neurol | 2016 | https://conductscience.org/library/papers/27323247 | PubMed |
| 16 | 25840462 | Amyloid biomarkers in Alzheimer's disease. | Trends Pharmacol Sci | 2015 | https://conductscience.org/library/papers/25840462 | PubMed |
| 17 | 31612245 | Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948. | Eur J Nucl Med Mol Imaging | 2020 | https://conductscience.org/library/papers/31612245 | PubMed |
| 18 | 32722745 | Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. | JAMA | 2020 | https://conductscience.org/library/papers/32722745 | PubMed |
| 19 | 32561678 | Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution. | Neurology | 2020 | https://conductscience.org/library/papers/32561678 | PubMed |
| 20 | 11603811 | Cortical Lewy body pathology in the diagnosis of dementia. | Acta Neuropathol | 2001 | https://conductscience.org/library/papers/11603811 | PubMed |
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42845560 | A Phase 2b randomized clinical trial of the oral p38α inhibitor neflamapimod in dementia with Lewy bodies (DLB). | Res Sq | 2026 | https://conductscience.org/library/papers/42845560 | PubMed |
| 42530129 | Validation of Plasma p-tau217 as a Biomarker of Prodromal Alzheimer's Disease. | Rev Neurol | 2026 | https://conductscience.org/library/papers/42530129 | PubMed |
| 42358599 | Distinct neurostructural, cognitive, and neuropsychiatric associations of plasma p-tau217, and Aβ42/40 in Parkinson's disease and aging cohorts. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42358599 | PubMed |
| 42319427 | Disease modification in advanced Parkinson's disease: a review and roadmap for paving the way for next-generation interventions. | J Neural Transm (Vienna) | 2026 | https://conductscience.org/library/papers/42319427 | PubMed |
| 41963316 | Plasma phosphorylated tau 217 detects amyloid-β in neuronal synuclein disease. | NPJ Parkinsons Dis | 2026 | https://conductscience.org/library/papers/41963316 | PubMed |
| 41929322 | Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease. | medRxiv | 2026 | https://conductscience.org/library/papers/41929322 | PubMed |
| 41880022 | Amyloid and Tau Co-pathology in Parkinson Disease and Atypical Parkinsonism. | Curr Neurol Neurosci Rep | 2026 | https://conductscience.org/library/papers/41880022 | PubMed |
| 41848292 | Association between Plasma P-tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease. | Ann Neurol | 2026 | https://conductscience.org/library/papers/41848292 | PubMed |
| 41603647 | Discordance of Dopaminergic Dysfunction and Subcortical Atrophy by α-Synuclein Status in Sporadic and Genetic Parkinson's Disease. | Mov Disord | 2026 | https://conductscience.org/library/papers/41603647 | PubMed |
| 41569009 | Serum phosphorylated tau 217 in GBA1 variant carriers with and without Parkinson disease. | J Parkinsons Dis | 2026 | https://conductscience.org/library/papers/41569009 | PubMed |
| 41432804 | Heterogeneity of dementia with lewy bodies: Insights from clinical presentations, neuropathology, and biomarkers. | Neurol Sci | 2025 | https://conductscience.org/library/papers/41432804 | PubMed |
| 41312760 | Serum p-tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior Disorder. | Ann Neurol | 2026 | https://conductscience.org/library/papers/41312760 | PubMed |
| 41299532 | Biomarkers for Lewy body diseases and other alpha-synucleinopathies in biofluids: current evidence and future directions. | J Transl Med | 2025 | https://conductscience.org/library/papers/41299532 | PubMed |
| 41146744 | Staging and markers in Parkinson's disease and Lewy body disorders: narrative review. | Ther Adv Chronic Dis | 2025 | https://conductscience.org/library/papers/41146744 | PubMed |
| 40895094 | Detecting amyloid and tau pathology in Parkinson's disease, 4R-tauopathies and control subjects with plasma pTau217. | Front Neurol | 2025 | https://conductscience.org/library/papers/40895094 | PubMed |
| 40868991 | Comorbid Pathologies and Their Impact on Dementia with Lewy Bodies-Current View. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40868991 | PubMed |
| 40791093 | Plasma tau biomarkers are distinctly associated with tau tangles and decreased with Lewy body pathology. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/40791093 | PubMed |
| 40768634 | Insights into Biomarkers of Alzheimer's Disease: From Core Markers to Emerging Directions. | Aging Dis | 2025 | https://conductscience.org/library/papers/40768634 | PubMed |
| 40476540 | Diagnostic performance of plasma p-tau217 and Aβ42/40 biomarkers in the outpatient memory clinic. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/40476540 | PubMed |
| 40439083 | Plasma Phosphorylated Tau181 as a Biomarker for Alzheimer's Disease Co-Pathology in Lewy Body Disease. | Mov Disord | 2025 | https://conductscience.org/library/papers/40439083 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| SNCA | 6622 | PubTator's text mining | https://conductscience.org/library/genes/6622 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33285015
GET https://conductscience.org/api/papers/v1/33285015/references?page=2